Profil
Julia G.
Butchko worked as Chief of Staff at Eli Lilly & Co. from 2018 to 2019.
From 2019 to 2024, Dr. Butchko was Chief Development Officer at Immunovant, Inc. in 2023 to 2024.
Dr. Butchko completed undergraduate studies at The State University of New York College at Fredonia and earned a doctorate from The Pennsylvania State University.
Anciens postes connus de Julia G. Butchko
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNOVANT, INC. | Directeur Technique/Scientifique/R&D | 01/05/2023 |
| ELI LILLY AND COMPANY | Responsable des Ressources Humaines | 01/06/2019 |
Formation de Julia G. Butchko
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
The State University of New York College at Fredonia
The State University of New York College at Fredonia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunovant, Inc.
Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
















